Skip to main content

Table 2 Primary and secondary endpoints in patients with or without anticoagulation in unmatched and matched cohorts

From: Hospitalized patients with isolated distal deep vein thrombosis: anticoagulation therapy or not?

  Unmatched PSM
non-AC n = 138 AC n = 288 p1 non-AC n = 111 AC n = 111 p2
Primary endpoint
PDVT/ PE, n (%) 7 (5.1) 14 (4.9) 0.925 6 (5.4) 3 (2.7) 0.499
PDVT, n (%) 7 (5.1) 12 (4.2) 0.672 6 (5.4) 3 (2.7) 0.499
PE, n (%) 1 (0.7) 4 (1.4) 1.000 1 (0.9) 0 (0.0) 1.000
All-cause mortality, n (%) 41 (29.7) 47 (16.3) 0.001 31 (27.9) 21 (18.9) 0.113
Thrombosis related death, n (%) 0 (0.0) 0 (0.0) - 0 (0.0) 0 (0.0) -
Cardiovascular death, n (%) 4 (2.9) 8 (2.8) 1.000 2 (1.8) 3 (2.7) 0.651
Secondary endpoint
Thrombosis resolution, n (%) 58 (42.0) 155 (53.8) 0.023 48 (43.2) 57 (51.4) 0.226
Bleeding, n (%) 9 (6.5) 8 (2.8) 0.065 6 (5.4) 5 (4.5) 0.757
  1. AC Anticoagulation, PDVT Proximal deep venous thrombosis, PE Pulmonary embolism, PSM Propensity score matching